Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
D-Luciferin for AML Bioluminescence Imaging
2026-09-11
D-Luciferin potassium salt connects stable firefly luciferase labeling with practical, longitudinal readouts of leukemia burden, treatment response, and tumor cell tracking. This guide explains how to build reproducible in vivo bioluminescence imaging and in vitro luciferase reporter assay workflows while keeping BLI results distinct from direct measurements of histone succinylation.
-
LY2109761 for TGF-β Signaling Workflows
2026-09-11
LY2109761 enables controlled interrogation of TGF-β-driven Smad signaling, cell-cycle arrest, invasion, fibrosis, and treatment response. This practical guide translates receptor inhibition into reproducible cell-based workflows, mechanism-focused assays, and troubleshooting strategies.
-
Astrocytic GAT-3 in Dentate Gyrus Memory
2026-09-10
The reference study identifies astrocytic GAT-3 as an active signaling component that converts GABA uptake into calcium-dependent regulation of dentate gyrus synaptic transmission. By linking GAT-3, reverse Na+/Ca2+ exchange, presynaptic GluN2B-containing NMDARs, and contextual fear memory, the work provides a mechanistic framework for studying glia-dependent hippocampal plasticity.
-
Recombinant Human EGF: Assays, Workflow & Tips
2026-09-10
Build more interpretable proliferation, migration, and signaling assays with recombinant human EGF, using validated activity and formulation parameters as experimental anchors. The workflow distinguishes EGF-driven migration from invasion and connects EGFR biology with practical cell-culture, mucosal, and troubleshooting decisions.
-
Spermine tetrahydrochloride: Workflow Guide
2026-09-09
Spermine tetrahydrochloride supports three distinct laboratory workflows: protoplast protection, protein crystallization, and polyphosphazene nanoparticle formation. This guide translates the DDX3 crystallization study into practical setup, optimization, and troubleshooting decisions while defining where neuroscience interpretations remain exploratory.
-
BI 2536: Translating PLK1 Biology into Cancer Insight
2026-09-09
BI 2536 offers more than a potent PLK1 perturbation: it creates a framework for connecting mitotic control, growth inhibition, apoptosis, and translational model design. This thought-leadership guide shows how to move from nanomolar activity to interpretable cancer biology by pairing mechanistic assays with disciplined viability measurements and tumor xenograft strategy.
-
WST-8 Glucose Uptake Assay Kit: Workflow Guide
2026-09-08
Build a non-radioactive glucose uptake workflow around the WST-8 Glucose Uptake Assay Kit, from 2-DG handling and plate setup to normalization and troubleshooting. The approach translates the Galectin-1–FIP200 findings into a practical functional readout for hepatic steatosis, insulin resistance, cancer metabolism research, and related cell models.
-
Intravesical p21 mRNA-LNP Therapy in Bladder Cancer
2026-09-08
The reference study develops an intravesical lipid nanoparticle platform for delivering chemically modified CDKN1A/p21 mRNA to bladder tumors. Its findings support localized tumor-suppressor replacement as a nonviral mRNA delivery strategy, while also defining important translational limitations involving formulation, dosing, and the absence of human efficacy data.
-
Halazone: From Water Disinfection to Ion-Channel Insight
2026-09-07
Halazone is an antimicrobial sulfonamide derivative whose oxidative chemistry creates a practical bridge between water microbiology and membrane electrophysiology. This thought-leadership guide examines how to use that dual profile strategically while separating validated findings from translational hypotheses.
-
Cefazedone PK/PD: From MIC to Assay Design
2026-09-07
Cefazedone (Refosporen) is examined through a PK/PD lens that connects MIC testing, free-drug exposure, and clinical interpretation. This evidence-led guide explains how the CAP study can improve antibacterial assay design without overstating limited clinical data.
-
Angiogenin Controls Endometrial Receptivity
2026-09-05
This study identifies stromal angiogenin as a mechanistic link between ovarian stimulation and defective endometrial epithelial remodeling. Its evidence connects estrogen receptor α-dependent angiogenin induction with increased rRNA transcription, altered epithelial differentiation, and impaired implantation, while genetic and pharmacological inhibition improved reproductive outcomes in mice.
-
RBMS1 Loss and PD-L1 Sensitization in TNBC
2026-09-04
The reference study identifies the RNA-binding protein RBMS1 as a tumor-intrinsic regulator of immune escape in triple-negative breast cancer. Its depletion destabilizes B4GALT1 mRNA, reduces PD-L1 glycosylation and stability, and improves T-cell-mediated tumor control, providing a mechanistic basis for combination immunotherapy strategies.
-
Tunable Human Intestinal Organoids: Study Insights
2026-09-04
Yang and colleagues developed a human small intestinal organoid system that increases cellular diversity without sacrificing proliferative capacity by strengthening stemness and then tuning lineage signals. The work provides a practical framework for shifting organoid fate reversibly or directing differentiation toward selected intestinal cell types under defined culture conditions.
-
MK 0893: Glucagon Receptor Antagonist Workflows
2026-09-03
MK 0893 enables mechanism-focused studies of GCGR binding, inhibition of cAMP production, and glucagon-driven glucose control. This guide connects cell-based potency testing with receptor-structure experiments, hGCGR animal models, and practical troubleshooting for reliable type 2 diabetes research.
-
Anagliptin: From DPP-4 to Vascular Translation
2026-09-03
Anagliptin (SK-0403) offers translational researchers a way to connect selective DPP-4 inhibition with vascular physiology. Evidence from rabbit aorta points to Kv channel and SERCA pump involvement, while defining the controls needed to move beyond glycemic endpoints.